3155.50 76.50 (2.48%)

29.02% Gain from 52W Low

61,817 NSE+BSE Volume High volume today

NSE Aug 08, 2022 03:31 PM



AstraZeneca Pharma India Ltd.    
08 Aug 2022, 07:19PM
3155.50
2.48%
ASTRAZENECA PHARMA INDIA LTD. - 506820 - Appointment of Company Secretary and Compliance Officer
BSE India
With reference to the captioned subject, we wish to inform you that Mr. Pratap Rudra, Company Secretary has resigned as Company Secretary and Compliance Officer of the Company with effect from close of working hours of August 10, 2022. While taking note of the same, the Board has placed on record its sincere thanks and appreciation for his contribution during his tenure in the Company. Further, the Board has appointed Ms. Manasa. R as the Company Secretary and Compliance Officer of the Company w.e.f. August 11, 2022.
AstraZeneca Pharma India Ltd.    
08 Aug 2022, 07:11PM
3155.50
2.48%
ASTRAZENECA PHARMA INDIA LTD. - 506820 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / …
BSE India
With reference to the captioned subject, we wish to inform you that Mr. Pratap Rudra, Company Secretary has resigned as Company Secretary and Compliance Officer of the Company with effect from close of working hours of August 10, 2022. While taking note of the same, the Board has placed on record its sincere thanks and appreciation for his contribution during his tenure in the Company.
AstraZeneca Pharma India Ltd.    
08 Aug 2022, 01:31PM
3155.50
2.48%
3155.50
2.48%
ASTRAZENECA PHARMA INDIA LTD. - 506820 - Board Meeting Intimation for Meeting Of The Board Of …
BSE India
ASTRAZENECA PHARMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2022 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of AstraZeneca Pharma India Limited will be held on Monday, August 8, 2022 inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2022. We would also like to inform you that the 'Trading Window' remains closed for all Designated Persons, from June 16, 2022 to August 10, 2022 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.
3155.50
2.48%
3155.50
2.48%
3155.50
2.48%
ASTRAZENECA PHARMA INDIA LTD. - 506820 - Statement Of Investor Complaints For The Quarter Ended June 2022
BSE India
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1010 Name of the Signatory :- Pratap Rudra Designation :- Company Secretary and Compliance Officer
3155.50
2.48%
ASTRAZENECA PHARMA INDIA LTD. - 506820 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …
BSE India
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agents of the Company, Integrated Registry Management Services Private Limited have informed the Company on the attached request for loss of share certificate from the claimant.
3155.50
2.48%
ASTRAZENECA PHARMA INDIA LTD. - 506820 - Reg. 34 (1) Annual Report.
BSE India
Pursuant to Regulation 34(1) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed the Annual Report of the Company for the financial year ended March 31, 2022 along with the Notice of the Annual General Meeting of the Company scheduled to be held on Monday, August 8, 2022 at 3.00 p.m. (IST) through Video Conferencing (VC)/ Other Audio Visual Means (OAVM). The Annual Report is being sent to the members who have registered their email ID with the Company/ Depositories. The Annual Report is also available on the website of the Company at www.astrazeneca.com/india.
3155.50
2.48%
ASTRAZENECA PHARMA INDIA LTD. - 506820 - Notice Of 43Rd Annual General Meeting
BSE India
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed the Notice of the 43rd Annual General Meeting of the Company scheduled to be held on Monday, August 8, 2022 at 3.00 p.m. (IST) through Video Conferencing (VC)/ Other Audio Visual Means (OAVM). The Notice is being sent to the members of the Company through electronic mode. The said Notice and the Annual Report for the financial year ended March 31, 2022 is available on the website of the Company at www.astrazeneca.com/india.
114 Votes:
Buy 71.05%
Sell 18.42%
Hold 10.53%
BUY
SELL
HOLD